(Rac)-Finerenone ((Rac)-BAY 94-8862) 是 Finerenone 的消旋体。Finerenone (BAY 94-8862) 是一种第三代、选择性、口服活性、非甾体类盐皮质激素受体 (MR) 拮抗剂，IC50 为 18 nM。Finerenone 对糖皮质激素受体 (GR)、雄激素受体 (AR) 和孕激素受体 (PR) 的选择性超过 500 倍。

Baxdrostat是一种选择性的醛固酮合成酶 (aldosterone synthase) 抑制剂，具有潜在的治疗高血压和相关心血管疾病的应用价值。

Apararenone (MT-3995) is a novel non-steroidal mineralocorticoid receptor antagonists under development for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis.

Finerenone is a novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonist with IC50 value of 18nM.

Esaxerenone is an aldosterone receptor antagonist. Esaxerenone may be potential useful for preventing or treating hypertension or disease caused by hypertension.

Eplerenone is both a selective aldosterone blocker and a CYP3A4 substrate.

Fludrocortisone Acetate

Vamorolone(VBP15) 是首创的口服解离性类固醇抗炎剂和膜稳定剂，能改善肌营养不良，无明显副作用，同时抑制 NF-κB 活性并减弱激素副作用。

Potassium canrenoate, the potassium salt of canrenoic acid, is an aldosterone antagonist of the spirolactone group.